• Harnessing Streptozotocin for Translational Breakthroughs...

  2025-10-20

  Streptozotocin (STZ) has long been the gold-standard DNA-alkylating agent for inducing diabetes in experimental models, but its role is rapidly expanding as translational researchers pivot toward complex neuroimmune and metabolic disease pathways. Integrating rigorous mechanistic insight with actionable strategy, this article explores the selective β-cell cytotoxicity of STZ, reviews its application in modeling both diabetes and its complications (such as painful diabetic neuropathy), and delivers forward-looking guidance for maximizing translational impact. Drawing from landmark studies and the latest advances—including TBK1-mediated microglia pyroptosis—this thought-leadership piece positions ApexBio’s Streptozotocin as an indispensable, precision tool for next-generation preclinical research.

• 7ACC2: Carboxycoumarin MCT1 Inhibitor for Cancer Metaboli...

  2025-10-19

  7ACC2 redefines cancer metabolism research by offering precise, dual inhibition of monocarboxylate transporter 1 (MCT1) and mitochondrial pyruvate transport. Its high potency and unique mechanistic profile enable advanced workflows for dissecting lactate uptake, immunometabolic crosstalk, and radiosensitization in tumor models.

407 records 28/28 page Previous First page 上5页 262728